This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Biomodal Limited, Cambridge Epigenetix Limited. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Michael Steward: Innovator in Nucleic Acid Analysis
Introduction
Michael Steward is a prominent inventor based in Royston, GB. He has made significant contributions to the field of nucleic acid analysis, particularly through his innovative methods and systems. His work is essential for advancing genetic research and diagnostics.
Latest Patents
Michael Steward holds a patent for "Methods for analyzing nucleic acids." This patent provides methods, systems, and compositions for determining a base in a polynucleotide. The techniques he developed are particularly useful for performing 4-base, 5-base, or 6-base sequencing of polynucleotide molecules. These methods can be applied to liquid biopsy samples, especially when identifying low-frequency mutations.
Career Highlights
Michael Steward is associated with Cambridge Epigenetix Limited, where he continues to push the boundaries of genetic analysis. His work has garnered attention for its potential applications in personalized medicine and cancer diagnostics.
Collaborations
Throughout his career, Michael has collaborated with notable scientists, including Shankar Balasubramanian and Jens Fullgrabe. These partnerships have enhanced the impact of his research and contributed to advancements in the field.
Conclusion
Michael Steward's innovative approaches to nucleic acid analysis exemplify the importance of research and development in genetics. His contributions are paving the way for future breakthroughs in medical diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile